Investing

Exelixis : EXEL

EXEL

Stock Data

$43.68

$0.78 (1.75%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Exelixis Inc is a pioneering oncology company dedicated to developing new treatments for challenging cancers. It is known for CABOMETYX tablets, aimed at advanced renal cell carcinoma patients, and COMETRIQ capsules for progressive, metastatic medullary thyroid cancer. Both drugs are based on cabozantinib, targeting multiple tyrosine kinases. Exelixis also works on COTELLIC for advanced melanoma and MINNEBRO for hypertension in Japan, among other innovative therapies. With a strong focus on research collaborations, Exelixis is at the forefront of cancer treatment advancements, headquartered in Alameda, California.

All Exelixis Articles

61 Articles

Trey Thoelcke | Jun 2, 2024 at 9:15 AM EDT

Insider Buying Heats Up at Fracker, Aircraft and Boat Makers, and More

In the past week, insiders returned to scoop up more shares of a fracking services company and a recreational boat…

Trey Thoelcke | Feb 27, 2024 at 8:45 AM EST

Stock Offerings Prompt Big Insider Buying

Public offerings of stock tempted some insider buying, and one insider stepped up to support a struggling online delivery service…

Lee Jackson | Jan 27, 2023 at 8:50 AM EST

Friday’s Top Analyst Upgrades and Downgrades: Datadog, Las Vegas Sands, Lyft, Nasdaq, Match, Pfizer, Walmart and More

Friday's top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era…

Lee Jackson | Oct 7, 2021 at 8:52 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: AT&T, Alibaba, Ally Financial, BioMarin, Box, Citrix Systems, Five Below, Nio, TJX and More

Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX…

Chris Lange | Jun 15, 2021 at 9:11 AM EDT

Tuesday Analyst Upgrades and Downgrades: Campbell Soup, Exact Sciences, Exelixis, Spirit Airlines, Sarepta, ZTO and More

Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.

Chris Lange | May 18, 2021 at 11:43 AM EDT

BioNTech, Exelixis, Foot Locker and More Tuesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali…

Jon C. Ogg | May 14, 2020 at 9:08 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, Baker Hughes, Best Buy, Cisco, CyberArk, Enphase, Grubhub, Jumia, SmileDirect, Under Armour, Wayfair and More

Thursday's top analyst upgrades and downgrades included Adobe, Baker Hughes, Best Buy, Cisco Systems, CyberArk Software, Enphase Energy, Grubhub, Jumia…

Chris Lange | Apr 20, 2020 at 9:47 AM EDT

Why This Late-Stage Kidney Cancer Study Could Be Huge

Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its…

Lee Jackson | Mar 18, 2019 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Chipotle, Delphi, Dollar General, Facebook, Ingersoll-Rand, Nike, Okta, Quest Diagnostics and More

The top analyst upgrades, downgrades and initiations seen on Monday included Chipotle Mexican Grill, Delphi Technologies, Dollar General, Facebook, Ingersoll-Rand,…

Jon C. Ogg | Feb 22, 2019 at 8:52 AM EST

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck,…

Lee Jackson | Jan 31, 2019 at 7:40 AM EST

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies…

Paul Ausick | Oct 15, 2018 at 4:04 PM EDT

Sears, Exelixis Drop into Monday’s 52-Week Low Club

Sears, Weyerhaeuser, Laredo Petroleum, and Exelixis were among the stocks posting new 52-week lows Monday.

Chris Lange | Oct 8, 2018 at 10:45 AM EDT

Exelixis Initiates Key Late-Stage Cancer Trial

Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory…

Paul Ausick | Sep 17, 2018 at 4:04 PM EDT

JD.com, Exelixis Stumble into Monday’s 52-Week Low Club

JD.com, Turquoise Hills, Exelixis, and Floor & Decor Holdings all posted new 52-week lows Monday.

Paul Ausick | Sep 13, 2018 at 4:04 PM EDT

Invesco, Chemours Slide into Thursday’s 52-Week Low Club

Invesco, Tal Education, Chemours, and Exelixis all posted new 52-week lows on Thursday.